Major side effects occur after coronary syndrome

Published Date: 13 Mar 2023

OSA itself predicted the incidence of MACCE in non-obese patients.

Read Full News

Latest News

An Old Theory Is Powering a New Approach to Doctor Burnout

A growing body of literature suggests that self-determination theory can help improve both provider well-being and patient care.

Finerenone Benefits Patients With T2D, CKD Across CKM Stages

In patients with T2D and CKD, finerenone lowers the risk for adverse cardiovascular and kidney events compared with placebo, regardless of the CKM syndrome stage at baseline.

Breastfeeding Linked to Lower Cardiometabolic Risk in PMOS

Exclusive breastfeeding is associated with a significant reduction in the cardiometabolic risk among women with polyendocrine metabolic ovarian syndrome after high-risk pregnancies.

Ultrasound Spots Heart Muscle Stiffening in Aortic Stenosis

Ultrafast ultrasound shear wave elastography may offer a feasible and non-invasive method to detect the stiffening of heart muscle in patients with congenital aortic stenosis, a study finds.

Cardiometabolic Issues: When to Suspect Sleep Apnea

Obstructive sleep apnea could be hiding behind subtle symptoms and uncontrolled cardiometabolic disease.

AI-Assisted POCUS Helps NPs, PAs Make Faster Cardiac Calls

New technology offers the ability for bed-side scans.

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Latest News

A growing body of literature suggests that self-determination theory can help improve both provider well-being and patient care.

In patients with T2D and CKD, finerenone lowers the risk for adverse cardiovascular and kidney events compared with placebo, regardless of the CKM syndrome stage at baseline.

Exclusive breastfeeding is associated with a significant reduction in the cardiometabolic risk among women with polyendocrine metabolic ovarian syndrome after high-risk pregnancies.

Ultrafast ultrasound shear wave elastography may offer a feasible and non-invasive method to detect the stiffening of heart muscle in patients with congenital aortic stenosis, a study finds.

Obstructive sleep apnea could be hiding behind subtle symptoms and uncontrolled cardiometabolic disease.

New technology offers the ability for bed-side scans.

News All Time

Sleepy Days and Restless Nights Linked to Hypertension Risk

Adults who report excessive daytime sleepiness and difficulty falling asleep face more than triple the risk of developing hypertension.

Gaps Exist in Cardiometabolic Risk Factor Treatment for CKM

Management of cardiometabolic risk factors for cardiovascular-kidney-metabolic syndrome falls short, particularly for younger adults, who have the lowest treatment rates.

Roosevelt’s Public Image and Overlooked Illness

A 2023 review reexamines Yalta through a medical lens, showing how Roosevelt’s deteriorating cardiovascular status may have been underestimated.

FDA Okays Drug to Curb Pancreatitis in Hypertriglyceridemia

The expanded indication makes olezarsen the first therapy approved to reduce the acute pancreatitis risk in adults with severe hypertriglyceridemia.

Statin Initiation Tied to Lower Frailty Risk in Older Adults

Starting statins is associated with a reduced risk for frailty in older adults, including those with prefrailty at baseline.

Synthetic Cannabinoids in Teens: What Clinicians Should Know

French authorities urge clinicians to consider synthetic cannabinoid exposure in adolescents presenting with unexplained neurologic, psychiatric, or cardiovascular symptoms.

Why Does the Heart Rarely Develop Cancer?

New findings suggest the heart’s mechanical activity actively restrains tumor growth, revealing a pathway that could inspire future cancer treatments.

New Vericiguat Analysis Shows Hidden Benefits in HF

Vericiguat may be beneficial for heart failure with reduced ejection fraction, according to a new study that accounted for mortality events occurring after heart failure hospitalization.

Inpatient Rehab Underutilized After Stroke, TBI

Fewer than 1 in 4 patients with stroke and fewer than 1 in 7 with traumatic brain injury are discharged from the hospital to an inpatient rehabilitation facility, new data show.

Early Treatment Cuts Heart Risk in Hypercholesterolaemia

Early treatment of FH in childhood and adolescence may reduce lifetime cholesterol burden and lower the cardiovascular risk compared to treatment starting later in adulthood.

Menopause Age Linked to Higher Hypercholesterolaemia Burden

Women experience a significant increase in hypercholesterolaemia diagnoses and related comorbidities around the menopausal transition compared with men.

Metyrapone Reduces BP in Mild Autonomous Cortisol Secretion

Evening metyrapone treatment reduces blood pressure at the supine position and epicardial fat in patients with mild autonomous cortisol secretion.

Ultraprocessed Foods: A Factor in Male Fertility Decline?

Emerging evidence links heavily processed dietary patterns to poor semen quality and hormonal changes that may influence reproductive health.

New Atrial Fibrillation May Speed Kidney Decline in Adults

In working-age adults, new-onset atrial fibrillation is linked to a faster decline in kidney function and a substantially higher risk of experiencing a 30% or greater reduction in kidney function.

Gene Therapy Appears to Be Safe in FA Cardiomyopathy

Intravenous gene therapy delivering the frataxin gene appears safe and is associated with preliminary signs of reduced heart damage in patients with Friedreich ataxia cardiomyopathy.

Glycemic Benefits of Testosterone Therapy Wane After 2 Years

A follow-up of the T4DM trial in men with prediabetes or recent-onset type 2 diabetes show no further glycemic improvement after 2 years without ongoing lifestyle modification.

Recommended News For You

10-year study shows tomosynthesis improves breast cancer detection

An Examine More Into the Acceptance of CRISPR/Cas9 Gene Therapy for Sickle Cell Illness.

tobacco use, the severity of their symptoms, and their desire to give up smoking among cancer survivors.

The acceptance of innovative hormonal therapy for advanced prostate cancer is racialized.

Classifying childhood brain cancers by immune response may improve diagnostics and treatments

Ignoring Colonoscopy Advice; Dry Mouth Acupuncture; Inflamed Tongue, Then Cancer.

Is Laughter Good for Blood Glucose Control?

Recommended Articles For You

Exploring the Hope of New Treatments for Rhabdomyosarcoma 

Pharmacological Frontier of Precision Oncology, Immunotherapies, and the Evolving Art of Treatment 

Imaging in Peritoneal Neoplasms: Diagnostic Advances and Multimodal Treatment Strategies 

Next-Gen Cancer Therapies: Radiopharmaceuticals, Immuno-Oncology, and Biologic Breakthroughs 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Worse Outcomes After Esophagectomy at Private Equity-Owned Hospitals

2.

How AI will transform mental health support for patients with breast cancer

3.

'It's rare and it's scary.' Dark spot on your fingernail could mean cancer

4.

In heavily pretreated DLBCL, Triplet Scores a Survival Victory.

5.

Breast cancer prevention: How nurse practitioners and physician assistants can help

1.

Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care

2.

Emerging Insights in Hematology for Better Care

3.

Survival Rate Dynamics in Hematologic and Solid Malignancies

4.

Unlocking the Potential of Lutathera: A Revolutionary Cancer Treatment

5.

Revolutionizing Cancer Treatment with Mercaptopurine: A New Hope for Patients

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

3.

Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV

5.

Navigating the Complexities of Ph Negative ALL - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot